Similarly, ALKBH5 also suppresses tumor progression in pancreatic cancer, lung cancer, and esophageal squamous cell carcinoma, with downstream targets such as PER1, YAP, and WIF-1 [27–29]. Here, PER1 is linked to esophageal squamous cell carcinoma.